Experienced in Blepharophimosis

Dr. Elizabeth R. Roeder

Medical Genetics | Pediatrics
San Antonio, TX 
Accepting New Patients
Experienced in Blepharophimosis
San Antonio, TX 
OverviewInsuranceLocationsClinical Research

Overview

Elizabeth Roeder is a Medical Genetics specialist and a Pediatrics provider in San Antonio, Texas. Dr. Roeder is rated as an Experienced provider by MediFind in the treatment of Blepharophimosis. Her top areas of expertise are Micrognathia, Ohdo Syndrome, Say-Barber-Biesecker-Young-Simpson Variant, Cornelia De Lange Syndrome, and Smith-Magenis Syndrome. Dr. Roeder is currently accepting new patients.

Her clinical research consists of co-authoring 50 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Blepharophimosis.

Specialties
Medical Genetics
Pediatrics
Licenses
Clinical Genetics in TX
Languages Spoken
English
Spanish
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Oscar
  • EPO
  • HMO
  • PPO

Locations

San Antonio, TX 78207

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of RAD011 (Cannabidiol Oral Solution) for the Treatment of Patients With Prader- Willi Syndrome
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of RAD011 (Cannabidiol Oral Solution) for the Treatment of Patients With Prader- Willi Syndrome
Enrollment Status: Terminated
Publish Date: October 19, 2023
Intervention Type: Drug
Study Drug: RAD011
Study Phase: Phase 2/Phase 3
Phase 3, Randomized, Double-Blind, Placebo-Controlled, 8-week Clinical Study to Assess the Efficacy, Safety, and Tolerability, of Intranasal Carbetocin (LV-101) in Prader-Willi Syndrome (PWS) With Long Term Follow-Up (CARE-PWS)
Phase 3, Randomized, Double-Blind, Placebo-Controlled, 8-week Clinical Study to Assess the Efficacy, Safety, and Tolerability, of Intranasal Carbetocin (LV-101) in Prader-Willi Syndrome (PWS) With Long Term Follow-Up (CARE-PWS)
Enrollment Status: Completed
Publish Date: July 26, 2022
Intervention Type: Drug
Study Drug: Intranasal carbetocin
Study Phase: Phase 3
View 1 Less Clinical Trial

50 Total Publications

A holistic approach is needed for women with an inflammatory arthritis in the different phases around pregnancy; the results of the CAPRI study.
A holistic approach is needed for women with an inflammatory arthritis in the different phases around pregnancy; the results of the CAPRI study.
Journal: Frontiers in global women's health
Published: October 07, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Roeder's expertise for a condition
ConditionClose
      View All 7 Advanced Conditions
      View All 16 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile